Cilazapril

Cilazapril
	File:Cilazapril.svg
Systematic (IUPAC) name
	(1S,9S)-9-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-10-oxo-octahydro-1H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid
Clinical data
Routes of; administration	Oral
Legal status
Legal status	UK: POM (Prescription only) ;
Identifiers
CAS Number	88768-40-5 92077-78-6
ATC code	C09AA08 (WHO)
PubChem	CID 56330
Chemical data
Formula	C22H33N3O6
Molar mass	435.514 g/mol[[Script error: No such module "String".]]

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Cilazapril is a pyridazine angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure. It is branded as Inhibace in Canada and New Zealand and Vascace and Dynorm in Europe. According to drugs.com (who have a partnership with the US Food & drug Administration) none of these are currently available in the United States as of May 2010.

References

Cilazapril monograph. Lexi-Comp Online, Lexi-Drugs Online, Lexi-Comp Inc. Hudson, OH. Available at: [1]. Accessed October 5th, 2008.

30px	This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. v d e